Clover Health to Report First Quarter 2025 Financial Results on May 6, 2025
Clover Health (Nasdaq: CLOV) has scheduled its First Quarter 2025 earnings release for Tuesday, May 6, 2025, after market close. The company will host a conference call and webcast at 5:00 p.m. Eastern Time on the same day to discuss the quarterly business and financial results.
Investors and interested parties can access the earnings call by dialing 800-274-8461 (U.S. callers) or 203-518-9814 (international callers) using the conference ID: CLOVQ125. A live webcast will be available through the Investor Relations section of Clover Health's website, with the recording remaining accessible for 12 months.
Clover Health (Nasdaq: CLOV) ha programmato il rilascio dei risultati finanziari del Primo Trimestre 2025 per martedì 6 maggio 2025, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica e un webcast alle 17:00 ora orientale dello stesso giorno per discutere i risultati finanziari e aziendali trimestrali.
Gli investitori e le parti interessate possono accedere alla chiamata sugli utili componendo il numero 800-274-8461 (chiamate dagli Stati Uniti) o 203-518-9814 (chiamate internazionali) utilizzando l'ID conferenza: CLOVQ125. Un webcast in diretta sarà disponibile nella sezione Relazioni con gli Investitori del sito web di Clover Health, con la registrazione che rimarrà accessibile per 12 mesi.
Clover Health (Nasdaq: CLOV) ha programado la publicación de resultados del Primer Trimestre 2025 para el martes 6 de mayo de 2025, después del cierre del mercado. La compañía llevará a cabo una conferencia telefónica y un webcast a las 5:00 p.m. hora del Este el mismo día para discutir los resultados financieros y comerciales trimestrales.
Los inversores y partes interesadas pueden acceder a la llamada de ganancias marcando el 800-274-8461 (llamadas de EE. UU.) o el 203-518-9814 (llamadas internacionales) utilizando el ID de conferencia: CLOVQ125. Se dispondrá de un webcast en vivo a través de la sección de Relaciones con Inversores del sitio web de Clover Health, con la grabación accesible durante 12 meses.
Clover Health (Nasdaq: CLOV)는 2025년 1분기 실적 발표를 2025년 5월 6일 화요일, 시장 종료 후에 예정하고 있습니다. 회사는 같은 날 동부 표준시 오후 5시에 분기별 비즈니스 및 재무 결과에 대해 논의하기 위해 전화 회의 및 웹캐스트를 개최할 것입니다.
투자자 및 이해관계자는 800-274-8461 (미국 전화) 또는 203-518-9814 (국제 전화)로 전화하여 회의 ID: CLOVQ125를 사용하여 실적 발표에 접근할 수 있습니다. Clover Health 웹사이트의 투자자 관계 섹션을 통해 실시간 웹캐스트를 제공하며, 녹화본은 12개월 동안 접근 가능합니다.
Clover Health (Nasdaq: CLOV) a programmé la publication de ses résultats du premier trimestre 2025 pour le mardi 6 mai 2025, après la fermeture du marché. L'entreprise organisera une conférence téléphonique et un webcast à 17h00, heure de l'Est, le même jour pour discuter des résultats financiers et commerciaux trimestriels.
Les investisseurs et les parties intéressées peuvent accéder à l'appel de résultats en composant le 800-274-8461 (appelants des États-Unis) ou le 203-518-9814 (appelants internationaux) en utilisant l'ID de conférence : CLOVQ125. Un webcast en direct sera disponible via la section Relations avec les investisseurs du site web de Clover Health, et l'enregistrement restera accessible pendant 12 mois.
Clover Health (Nasdaq: CLOV) hat die Veröffentlichung der Ergebnisse für das erste Quartal 2025 auf Dienstag, den 6. Mai 2025, nach Börsenschluss terminiert. Das Unternehmen wird am selben Tag um 17:00 Uhr Eastern Time eine Telefonkonferenz und einen Webcast abhalten, um die vierteljährlichen Geschäfts- und Finanzergebnisse zu besprechen.
Investoren und interessierte Parteien können die Gewinnanrufnummer 800-274-8461 (USA) oder 203-518-9814 (international) wählen und die Konferenz-ID: CLOVQ125 verwenden. Ein Live-Webcast wird über den Bereich Investor Relations auf der Website von Clover Health verfügbar sein, und die Aufzeichnung bleibt für 12 Monate zugänglich.
- None.
- None.
WILMINGTON, Del., April 08, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that it will report first quarter 2025 financial results after market close on Tuesday, May 6, 2025. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on May 6, 2025, to discuss Clover Health’s first quarter 2025 business and financial results.
First Quarter 2025 Conference Call and Webcast Details:
- What: Clover Health’s First Quarter 2025 Earnings Conference Call
- When: Tuesday, May 6, 2025, at 5:00 p.m. Eastern Time
- Dial In: To access the call via telephone please dial 800-274-8461 (for U.S. callers) or 203-518-9814 (for callers outside the U.S.) and enter the conference ID: CLOVQ125
- Webcast: A live and archived webcast of the conference call will be accessible from the Investor Relations section of Clover Health’s website at https://investors.cloverhealth.com/ for 12 months
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Investor Relations:
Ryan Schmidt
investors@cloverhealth.com
Press Inquiries:
press@cloverhealth.com
